The role of leukotriene modifying agent treatment in neuropsychiatric events of elderly asthma patients: a nested case control study

The role of leukotriene modifying agent treatment in neuropsychiatric events of elderly asthma patients: a nested case control study

Abstract Background In March 2020, the US Food and Drug Administration decided that the dangers related to neuropsychiatric events (NPEs) of montelukast, one of the leukotriene modifying agents (LTMAs), should be communicated through ‘boxed warning’. In case of NPEs, the prevalence has been the high...

Full description

Bibliographic Details
Main Authors: Sang Oh Kang, Kyung Hyun Min, Hyun Jeong Kim, Tae Hyeok Kim, Woorim Kim, Kyung Eun Lee
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Asthma Research and Practice
Subjects:
Leukotriene modifying agent
Neuropsychiatric events
National health insurance service database
South Korea
Asthma
Nested case-control study
Online Access:https://doi.org/10.1186/s40733-021-00070-4

Internet

https://doi.org/10.1186/s40733-021-00070-4

Similar Items